BioHarvest Sciences (BHST) investor relations material

Mission and vision

• Focused on addressing unmet health and wellness needs with patentable plant compounds produced sustainably and economically.

• Aims to discover, develop, manufacture, and democratize life-changing plant-based compounds for global health and wellness while preserving the planet.

Technology and platform

• Invented botanical synthesis, isolating and maximizing phytonutrients by growing only plant cells, not whole plants.

• Over $100M invested in a patented platform with 14 granted patents and multiple pending.

• Facilities optimized for industrial production, requiring low CapEx and offering high ROI; $5M investment can yield $60M in annual revenue.

• Process enables consistent, clean, non-GMO, and highly potent compounds with significant environmental and economic advantages.

Product portfolio and growth engines

• Two main growth engines: direct-to-consumer (D2C) packaged products and CDMO services for plant-based compounds.

• Flagship product VINIA® has achieved over $84M in sales since 2021, with 85,000+ active customers and strong clinical validation.

• Expanding product lines include hydration powders, chews, coffee, tea, and future launches based on olive and pomegranate cell powders.

• CDMO division has signed four deals across cosmetics, pharma, nutraceuticals, and sweeteners, with a robust pipeline and multi-billion-dollar market opportunities.